Rheumatology Advance Access published online on February 15, 2008
Rheumatology, doi:10.1093/rheumatology/ken011
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Editorial |
Conservative management for tendinopathy: is there enough scientific evidence?
1Department of Trauma and Orthopaedic Surgery, University Hospital of North Staffordshire, Keele University School of Medicine, Stoke on Trent ST4 7LN, UK and 2Department of Orthopaedic and Trauma Surgery, Campus Biomedico University, Via Longoni, 83, 00155 Rome, Italy
Correspondence to:
Correspondence to: N. Maffulli, Department of Trauma and Orthopaedic Surgery, Keele University School of Medicine, Thornburrow Drive, Hartshill, Stoke on Trent, Staffs, ST4 7QB UK. E-mail: n.maffulli@keele.ac.uk
| The first 150 words of the full text of this article appear below. |
Tendinopathies account for a substantial proportion of overuse injuries in sports, and are prevalent in the workplace. The essence of tendinopathy is a failed healing response, with haphazard proliferation of tenocytes, some evidence of degeneration in tendon cells and disruption of collagen fibres and subsequent increase in non-collagenous matrix [1, 2]. Over the past few years, various new therapeutic options have been proposed for the management of tendinopathy. Despite the morbidity associated with tendinopathy in athletes, management is far from scientifically based, and many of the therapeutic options described and in common use lack hard scientific background.
Physical therapy, rest, training modification, splintage, taping, cryotherapy, electrotherapy, shock wave therapy, hyperthermia, pharmaceutical agents, such as NSAIDs and various peri-tendinous injections, have all been proposed most essentially to follow the same principles. Managements that have been investigated with randomized controlled trials include non-steroidal anti-inflammatory medication, eccentric exercise, glyceryl trinitrate